logo
Select company
Select metric
64.21%Gross Profits to Assets
VS
Market
93
Sector
92
Industry
95
History
85
$ 8.3Close
$ 6.41 - $ 16.8 52-Week Range
Ticker Information

Ticker

GYRE

Company Name

GYRE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GYRE THERAPEUTICS INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GYRE - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
6/30/2025$ 152.65M$ 98.01M64.21%
3/31/2025$ 129.79M$ 96.84M74.62%
12/31/2024$ 125.41M$ 101.87M81.23%
9/30/2024$ 125.24M$ 183.99M146.91%
6/30/2024$ 120.93M$ 159.46M131.86%
3/31/2024$ 122.01M$ 135.01M110.65%
12/31/2023$ 116.54M$ 108.81M93.37%
9/30/2023$ 9.96M$ 00%
6/30/2023$ 12.39M$ 00%
3/31/2023$ 18.75M$ 00%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GYRE THERAPEUTICS INC's latest trailing twelve months (TTM) GPA stands at 10.54%.
  • Over the past 5 years, GYRE THERAPEUTICS INC's average GPA has been 36.27%.
  • The median GPA for GYRE THERAPEUTICS INC during this period was 0%
  • GYRE THERAPEUTICS INC reached its highest GPA over the past 5 years at 146.91%.
  • The lowest GPA recorded by GYRE THERAPEUTICS INC in the same timeframe -0.1%

GYRE THERAPEUTICS INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
PHAT : PHATHOM PHARMACEUTICALS INC 39.61%NAGE : NIAGEN BIOSCIENCE INC 80.85%ANAB : ANAPTYSBIO INC 36.74%TBPH : THERAVANCE BIOPHARMA INC 18.12%URGN : UROGEN PHARMA LTD 39.97%CRMD : CORMEDIX INC 45.99%NRIX : NURIX THERAPEUTICS INC 16.02%ZVRA : ZEVRA THERAPEUTICS INC 17.41%KURA : KURA ONCOLOGY INC 12.2%SAGE : SAGE THERAPEUTICS INC 14.91%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for GYRE THERAPEUTICS INC is calculated as follows: GP [ $ 11.79M ] / Assets [ $ 111.8M ]
(=) GPA [ 10.54% ]

GYRE - Gross Profits to Assets, Last 5 years

-0.1%

Minimum

Mar 31, 2021

146.91%

Maximum

Sep 30, 2024

36.27%

Average

0%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.13K
min-50.32%
max83.98%
average20.16%
median15.35%
std19.95%